Oculoplastic labs, neoplasms and rosacea research
Pilot evaluation for an image-based eyelid lesion management service
Dr Anna March de Ribot4 min read
Advertisement
Pilot evaluation for an image-based eyelid lesion management service
Diabetes has been described as one of the biggest epidemics of the 21st century. By 2045, 783 million people are projected to have developed diabetes globally1. In 2021 alone, diabetes resulted in 6.7 million deaths worldwide and US$966 billion in global healthcare spending1.
I remember when I first looked through a kaleidoscope; it was a magical thing that you pointed towards the light, rotated the end piece and all the shapes and colours exploded. I reckon my brain's going a bit like that.
Have you ever asked yourself if your practice feels safe and welcoming for people from rainbow communities? If you are asking yourself why that would even matter, since you just look at people’s eyes… well, it matters a lot. Rainbow people often delay, or completely stay away from, preventative and
The world of ocular surface health has lately sprawled, owing to a rapid, radical revolution in understanding and practice. How did we get there as a field and, more importantly, how can you get there as a clinician, and keep up?
Ophthalmology New Zealand (ONZ) is the business arm of ophthalmology in New Zealand. In contrast to, and perhaps synergistic with the RANZCO NZ branch, ONZ fulfills a number of critical roles, supported by our overall strategic plan: www.ophthalmologynz.co.nz.
Much like the rest of the world, the Mido Eyewear Show had to endure a two-year hiatus, eventually taking place on 30 April-2 May 2022, belatedly celebrating Mido’s 50th anniversary.
The final Ocular Therapeutics Evening (OTE) of the University of Auckland’s Buchanan Ocular Therapeutics Unit (BOTU) series was held online and focused on paediatric eyecare.
Glaucoma suspects using a self-administered iPad test for visual field defects took a third of the time of traditional in-clinic testing and achieved greater sensitivity, reported Australian researchers.
After two years of limited or cancelled meetings due to Covid-19, it was a breath of fresh air to arrive at Blenheim’s Marlborough Events Centre and ASB Theatre for the RANZCO NZ Branch meeting. Amid the lingering pandemic and ever-changing gathering restrictions, RANZCO’s conference committee and o
Adaptability in challenging times was the theme of the 2022 RANZCO New Zealand branch meeting in Blenheim. As with the main sessions, shared with the ophthalmologists, the ophthalmic nurses and allied health component of the conference reflected a health sector rapidly adapting to the pandemic’s ong
In December 2021, we described normal variations in the iris and iris changes in certain genetic conditions, systemic diseases, and malignant tumours. In the second part of this mini-series, we explore eye conditions resulting in iris transillumination defects and rubeosis.